Corvus Pharmaceuticals to Provide Business Update and Report First Quarter 2020 Financial Results on April 30, 2020

NEXT STORY
Itamar™ Medical Funds Clinical Study to Evaluate Potential Impact of CPAP Therapy to Patients with COVID-19 
PREV STORY
Agile Therapeutics Announces Changes to its Board of Directors
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Ritter Pharmaceuticals, Inc. Raises $23 Million to Fund Initiation of Its Phase 3 Clinical Program in Lactose Intolerance

Los Angeles, California,, Oct. 03, 2017 (GLOBE NEWSWIRE) -- Ritter Pharmaceuticals, Inc. (NASDAQ: RTTR) ...

author_avatar
NASDAQ Market News

TiGenix: Transparency notification pursuant to Article 14 of the Law of May 2, 2007

REGULATED INFORMATIONPRESS RELEASE Transparency notification pursuant to Article 14 of the Law of May ...

author_avatar
NASDAQ Market News

Kevin McCann and Mark Nelson Appointed to the Board of Directors of Telix Pharmaceuticals Limited

MELBOURNE, Australia, Sept. 18, 2017 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (“Telix”, the “Company”) ...

author_avatar
NASDAQ Market News